| abstract |
There is described the compound (+) - (2S, 3S) -2- (3-chlorophyll) -3, - tty-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, pharmaceutical compositions containing these, and it is also described a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease, Alzheimer's disease or cocaine or nicotine-containing (especially tobacco) drug use using such a compound, salts, solvates or compositions. |